B

Biohaven Ltd

D
BHVN
USD
-0.645
(-1.2013%)
Market Closed
24,499.00
Volume
-8.764
EPS
-
Div Yield
-5.703763
P/E
5,014,993,810.39
Market Cap
Today
-0.9245%
1 Week
6.687%
1 Month
0.483%
6 Months
27.912%
12 Months
75.413%
Year To Date
23.937%
All Time
0%

Title:
Biohaven Ltd

Sector:
Healthcare
Industry:
Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Do you need help or have a question?